EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Assessing cost-effectiveness in oncology treatment sequences: a review of pathway modeling methods for health technology assessment

Lucy Beggs iD, Kusal Lokuge, Ayman Sadek, Nicky J Welton, Amy Finnegan, David Nicholls, Lindsay Claxton

International Journal of Technology Assessment in Health Care · 2026

DOI: 10.1017/s0266462326103869 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Technology Assessment in Health Care, 2026. Verfasst von Lucy Beggs und 6 weiteren Autor:innen. Beteiligte Einrichtung: https://ror.org/015ah0c92National Institute for Health and Care Excellence, UK. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Neoplasms, Critical Pathways, Medical Oncology. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Pathway models incorporate multiple decision nodes to assess the most cost-effective sequence or the optimal point of introduction of a new technology within a treatment pathway. Pathway models are particularly useful in disease areas such as oncology, where patients may have several lines of therapy. We aimed to review methodologies for modeling and evidence synthesis in pathway models that evaluate the cost-effectiveness of treatment strategies within oncology.

Methods

We designed a search to identify relevant methodological papers and systematic reviews of oncology pathway models that critique their methodological approaches. We also updated a previous review of studies on methods for evidence synthesis to inform pathway models. Best practice recommendations were extracted and summarized.

Results

Nine and five studies were included on methods for model structures and evidence synthesis, respectively. Key themes related to data requirements, including a preference for patient-level model structures and data from multi-line sources. There was limited guidance on alternative model structures in the absence of patient-level data. Multi-state network meta-analysis with flexible survival models was the most appropriate method identified for evidence synthesis; however, due to data limitations, it may be necessary to conduct separate syntheses at each line of therapy.

Conclusions

Data limitations may reduce the potential benefits of pathway models. Further method development is needed for pathway models in decision spaces where individual patient data and sources that cover multiple lines of treatment are not available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalNeoplasmsCritical PathwaysMedical OncologyCost-Benefit AnalysisHumansCost-Effectiveness AnalysisDecision Support Techniques

Stichwörter der Autor:innen

economicevidence synthesismedical oncologymethodologymodelstreatment sequences

Autor:innen und Institutionen

  • https://ror.org/015ah0c92National Institute for Health and Care Excellence, UK.
  • https://ror.org/0524sp257University of Bristol, UK.

ORCID-Profile: Lucy Beggs

Zitieren

APA

Beggs, L., Lokuge, K., Sadek, A., Welton, N. J., Finnegan, A., Nicholls, D., & Claxton, L. (2026). Assessing cost-effectiveness in oncology treatment sequences: a review of pathway modeling methods for health technology assessment. International Journal of Technology Assessment in Health Care. https://doi.org/10.1017/s0266462326103869

Vancouver

Beggs L, Lokuge K, Sadek A, Welton NJ, Finnegan A, Nicholls D, et al. Assessing cost-effectiveness in oncology treatment sequences: a review of pathway modeling methods for health technology assessment. International Journal of Technology Assessment in Health Care. 2026. doi:10.1017/s0266462326103869

BibTeX
@article{Beggs2026,
  author = {Beggs, Lucy and Lokuge, Kusal and Sadek, Ayman and Welton, Nicky J and Finnegan, Amy and Nicholls, David and Claxton, Lindsay},
  title = {Assessing cost-effectiveness in oncology treatment sequences: a review of pathway modeling methods for health technology assessment},
  journal = {International Journal of Technology Assessment in Health Care},
  year = {2026},
  doi = {10.1017/s0266462326103869}
}
Kostenlos starten →